DELIVRA HEALTH BRANDS INC (DHB.CA) Stock Overview
Canada - TSX-V:DHB - CA24703H2019 - Common Stock
DHB.CA Key Statistics, Chart & Performance
The current stock price of DHB.CA is 0.2 CAD. In the past month the price decreased by -16.67%. In the past year, price decreased by -20%.
DHB.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.8 | 3.49B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.83B | ||
| CRON.CA | CRONOS GROUP INC | 51 | 1.37B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.92 | 821.23M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 615.84M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.89 | 580.05M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 484.32M | ||
| HITI.CA | HIGH TIDE INC | N/A | 439.75M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 26.62 | 431.45M | ||
| TSND.CA | TERRASCEND CORP | N/A | 406.71M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 391.50M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 330.45M |
Related stock screener links
About DHB.CA
Company Profile
Delivra Health Brands, Inc. is a cannabis company, which develops and provides lifestyle and wellness products to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. The company features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.
Company Info
DELIVRA HEALTH BRANDS INC
Suite 404, 999 Canada Place
Vancouver BRITISH COLUMBIA CA
Employees: 27
Phone: 16044499280
DELIVRA HEALTH BRANDS INC / DHB.CA FAQ
What is the stock price of DELIVRA HEALTH BRANDS INC today?
The current stock price of DHB.CA is 0.2 CAD.
What is the ticker symbol for DELIVRA HEALTH BRANDS INC stock?
The exchange symbol of DELIVRA HEALTH BRANDS INC is DHB and it is listed on the TSX Venture Exchange exchange.
On which exchange is DHB.CA stock listed?
DHB.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for DELIVRA HEALTH BRANDS INC stock?
9 analysts have analysed DHB.CA and the average price target is 0.73 CAD. This implies a price increase of 267.2% is expected in the next year compared to the current price of 0.2. Check the DELIVRA HEALTH BRANDS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DELIVRA HEALTH BRANDS INC worth?
DELIVRA HEALTH BRANDS INC (DHB.CA) has a market capitalization of 6.25M CAD. This makes DHB.CA a Nano Cap stock.
How many employees does DELIVRA HEALTH BRANDS INC have?
DELIVRA HEALTH BRANDS INC (DHB.CA) currently has 27 employees.
What are the support and resistance levels for DELIVRA HEALTH BRANDS INC (DHB.CA) stock?
DELIVRA HEALTH BRANDS INC (DHB.CA) has a support level at 0.19 and a resistance level at 0.21. Check the full technical report for a detailed analysis of DHB.CA support and resistance levels.
Is DELIVRA HEALTH BRANDS INC (DHB.CA) expected to grow?
The Revenue of DELIVRA HEALTH BRANDS INC (DHB.CA) is expected to grow by 4.45% in the next year. Check the estimates tab for more information on the DHB.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DELIVRA HEALTH BRANDS INC (DHB.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DHB.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DHB.CA, evaluating the profitability, health, valuation and growth aspects
- DELIVRA HEALTH BRANDS INC (DHB.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Sales and EPS estimates to see what analysts future expectations are.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- DELIVRA HEALTH BRANDS INC (DHB.CA) Stock Chart to make your own analysis
- DELIVRA HEALTH BRANDS INC (DHB.CA) Latest news and press-releases to stay up to date.
Does DELIVRA HEALTH BRANDS INC (DHB.CA) stock pay dividends?
DHB.CA does not pay a dividend.
When does DELIVRA HEALTH BRANDS INC (DHB.CA) report earnings?
DELIVRA HEALTH BRANDS INC (DHB.CA) will report earnings on 2025-10-06.
DHB.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to DHB.CA. When comparing the yearly performance of all stocks, DHB.CA is a bad performer in the overall market: 84% of all stocks are doing better.
DHB.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DHB.CA. DHB.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
DHB.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.56% | ||
| ROE | -3.18% | ||
| Debt/Equity | 0.47 |
DHB.CA Forecast & Estimates
9 analysts have analysed DHB.CA and the average price target is 0.73 CAD. This implies a price increase of 267.2% is expected in the next year compared to the current price of 0.2.